Genvax Revenue and Competitors

Ames, IA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Genvax's estimated annual revenue is currently $1.2M per year.(i)
  • Genvax's estimated revenue per employee is $77,500

Employee Data

  • Genvax has 15 Employees.(i)
  • Genvax grew their employee count by 67% last year.

Genvax's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Co-founderReveal Email/Phone
3
Chief Scientific OfficerReveal Email/Phone
4
VP Research & DevelopmentReveal Email/Phone
5
VP Staff and FacilitiesReveal Email/Phone
6
Manager NanovaccinesReveal Email/Phone
7
Administrative AssociateReveal Email/Phone
8
Laboratory TechnicianReveal Email/Phone
9
Lab TechnicianReveal Email/Phone
10
R&D ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.7M1183%N/AN/A
#2
$16.6M1073%N/AN/A
#3
$1.6M2140%$9.1MN/A
#4
$537.2M21666%$31.2MN/A
#5
$8.8M5710%N/AN/A
#6
$2.8M1838%N/AN/A
#7
$0.3M20%N/AN/A
#8
$0.2M10%N/AN/A
#9
$10.1M6520%N/AN/A
#10
$2.2M2840%N/AN/A
Add Company

What Is Genvax?

Genvax is a startup animal vaccine company located in Ames, Iowa. We have a dynamic team of experienced scientists and entrepreneurs poised to develop next generation mRNA + nanoparticle vaccines. This isn’t the first go-around for co-founders Joel Harris and Dr. Hank Harris, who successfully created, grew and sold Harrisvaccines to Merck Animal Health in 2015. Our Mission: Genvax Technologies accelerates breakthrough solutions to the animal health industry. We commercialize the tools for livestock producers and veterinarians that no one else can. Our Vision: We believe in rapidly responding to the world around us. We cultivate new ideas to develop novel solutions and create a long-lasting impact on animal health world-wide.

keywords:N/A

N/A

Total Funding

15

Number of Employees

$1.2M

Revenue (est)

67%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.5M160%N/A
#2
$2.6M170%N/A
#3
$1.7M19-5%N/A
#4
$2M20-26%N/A
#5
$2.4M24N/AN/A